Chimerix Inc (NAS:CMRX)
$ 0.938 -0.0042 (-0.45%) Market Cap: 84.07 Mil Enterprise Value: -73.57 Mil PE Ratio: 0 PB Ratio: 0.48 GF Score: 53/100

Q2 2021 Chimerix Inc Earnings Call Transcript

Aug 05, 2021 / 12:30PM GMT
Release Date Price: $6.73 (+3.86%)
Operator

Good morning, ladies and gentlemen, and welcome to the Chimerix Second Quarter 2021 Earnings Conference Call. I would now like to introduce your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.

Michelle LaSpaluto
Chimerix, Inc. - VP of Strategic Planning & IR

Thank you. Good morning, everyone, and welcome to the Chimerix Second Quarter 2021 Financial and Operating Results Conference Call. This morning, we issued a press release which outlines the topics we plan to discuss today. You can access the press release in our Investors section of the website.

With me on today's call are President and Chief Executive Officer, Mike Sherman; and Chief Financial and Business Officer, Mike Andriole. Allen Melemed, our Chief Medical Officer; and Josh Allen, our Chief Technology Officer of Imipridones, are here to participate in Q&A.

Before we begin, I would like to remind you that statements made on today's call include forward-looking statements within the meaning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot